Evidence map›Paper›PMID 28345670›Full record

ArticleNature communications2017

Domain-dependent effects of insulin and IGF-1 receptors on signalling and gene expression.

Weikang Cai, Masaji Sakaguchi, Andre Kleinridders, Gonzalo Gonzalez-Del Pino, Jonathan M Dreyfuss, Brian T O'Neill, Alfred K Ramirez, Hui Pan, Jonathon N Winnay, Jeremie Boucher and 2 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 96 papers.

0numbers the graph read from it
0cells of the map it votes in
96citing papers in PubMed
9.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

96 citing papers in PubMed, 171 citations in OpenAlex.

  1. Review
  2. Article
  3. Antibody-Based Biologics for CNS Disorders.Antibodies (Basel, Switzerland) · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. The insulin signalling network.Nature metabolism · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

36 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Weikang CaiSection of Integrative Physiology and Metabolism, Joslin Diabetes Center, Boston, Massachusetts 02215, USA.
Masaji SakaguchiSection of Integrative Physiology and Metabolism, Joslin Diabetes Center, Boston, Massachusetts 02215, USA.
Andre KleinriddersSection of Integrative Physiology and Metabolism, Joslin Diabetes Center, Boston, Massachusetts 02215, USA.
Gonzalo Gonzalez-Del PinoDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.
Jonathan M DreyfussBioinformatics Core, Joslin Diabetes Center, Boston, Massachusetts 02215, USA.
Brian T O'NeillSection of Integrative Physiology and Metabolism, Joslin Diabetes Center, Boston, Massachusetts 02215, USA.
Alfred K RamirezSection of Integrative Physiology and Metabolism, Joslin Diabetes Center, Boston, Massachusetts 02215, USA.
Hui PanBioinformatics Core, Joslin Diabetes Center, Boston, Massachusetts 02215, USA.
Jonathon N WinnaySection of Integrative Physiology and Metabolism, Joslin Diabetes Center, Boston, Massachusetts 02215, USA.
Jeremie BoucherSection of Integrative Physiology and Metabolism, Joslin Diabetes Center, Boston, Massachusetts 02215, USA.
Michael J EckDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, Massachusetts 02215, USA.
C Ronald KahnSection of Integrative Physiology and Metabolism, Joslin Diabetes Center, Boston, Massachusetts 02215, USA.
Harvard University · USJoslin Diabetes Center · USBoston University · US

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI LAURIE J GOODYEAR · 1986 to 2026
$50.5M
TRAINING IN DIABETES AND METABOLISMT32DK007260 · NIDDK · JOSLIN DIABETES CENTER · PI LAURIE J GOODYEAR · 1986 to 2026
$13.6M
INSULIN RECEPTOR STRUCTURE AND TURNOVERR37DK031036 · NIDDK · JOSLIN DIABETES CENTER · PI KAHN, C RONALD · 2000 to 2019
$12.9M
Insulin Receptor Substrates and Insulin ActionR01DK033201 · NIDDK · JOSLIN DIABETES CENTER · PI KAHN, C RONALD · 1986 to 2016
$10.6M
The Insulin Receptor and Its Signaling MechanismsR01DK031036 · NIDDK · JOSLIN DIABETES CENTER · PI C RONALD KAHN · 1986 to 2026
$4.2M
Regulation of Muscle Autophagy and Mitophagy by Insulin and IGF-1 SignalingK08DK100543 · NIDDK · UNIVERSITY OF IOWA · PI O'NEILL, BRIAN TIMOTHY · 2013 to 2017
$737k
NIDDK NIH HHS K08 DK100543NIDDK NIH HHS P30 DK036836NIDDK NIH HHS R01 DK031036NIDDK NIH HHS R01 DK033201NIDDK NIH HHS R37 DK031036NIDDK NIH HHS T32 DK007260
6 · The paper itself

Abstract

Despite a high degree of homology, insulin receptor (IR) and IGF-1 receptor (IGF1R) mediate distinct cellular and physiological functions. Here, we demonstrate how domain differences between IR and IGF1R contribute to the distinct functions of these receptors using chimeric and site-mutated receptors. Receptors with the intracellular domain of IGF1R show increased activation of Shc and Gab-1 and more potent regulation of genes involved in proliferation, corresponding to their higher mitogenic activity. Conversely, receptors with the intracellular domain of IR display higher IRS-1 phosphorylation, stronger regulation of genes in metabolic pathways and more dramatic glycolytic responses to hormonal stimulation. Strikingly, replacement of leucine

Indexed as

Gene ExpressionSignal TransductionAmino Acid SubstitutionAnimalsBinding SitesCell ProliferationGene Expression RegulationGlycolysisInsulinLeucineMiceMutagenesis, Site-DirectedPhenylalanineReceptor, IGF Type 1InsulinLeucinePhenylalanineReceptor, IGF Type 1

Identifiers

PMID28345670
PMCPMC5378997
OpenAlexW2604014584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.